Claims
What was said, typed and attributed. Statements as reported by the cited publishers — not verified by DecisionGateway.
Follow via RSS — the 30 newest claims in any reader, no account needed.
Claims by
statementThe game segment saw domestic mobile strength from webboard revenue and Chuseok effects despite the high base of Japanese mobile games in the prior quarter.신한생각statementThe payment segment set record highs, with NHN KCP transaction value of 17.3 trillion won and overseas merchant transaction share of 25.3%.신한생각statementThe investment opinion 'Buy' is maintained and the target price is raised 19.2% to 94,000 won, applying a target multiple of 18x to 12-month forward EPS of 4,858 won.신한생각predictionThe 27F AI DC revenue is estimated at 190.8 billion won and operating profit at 46 billion won.신한생각statementNHN will build 1,700 B300 units through a new capital-area base, with service scheduled to begin in January 2027.신한생각statementIn addition to the previously announced Pohang leased 20MW and self-built 10MW, NHN added Jangseong Pine DC 26MW and Seoul Gasan/Incheon Gajwa 6MW.신한생각statementNHN announced a plan to operate about 100MW of AI DC including existing facilities by 27F, with new capacity of 62MW, of which 52MW is leased.신한생각statementNHN recorded 3Q26 operating revenue of 758.3 billion won (YoY +21.2%, QoQ -0.1%) and operating profit of 58.8 billion won (YoY +112.7%, QoQ +33.6%, operating margin 5.1%), exceeding the consensus operating profit of 53.9 billion won.신한생각prediction목표주가 260,000원(SOTP Valuation)을 유지하며, 향후 글로벌 식품 성장성이 중장기 밸류에이션 레벨을 결정할 것으로 본다.신한생각prediction곡물가격 상승에 따른 판가 상승과 미국·브라질·EU 등 주요 권역의 중국산 라이신 반덤핑 관세 부과 등 변화가 동사에 우호적으로 작용하며 이익 기여도가 확대될 전망이다.신한생각statement바이오는 부진을 통과하나 원가 부담으로 식품 부진이 지속되고 있다.신한생각statementCJ대한통운을 제외한 매출과 영업이익은 4조 2,300억원(-7.5%), 2,030억원(+6.9%)을 기록했다.신한생각statement3Q26 매출과 영업이익은 7조 3,952억원(-0.6%, YoY), 3,090억원(-10.8%)을 기록해 컨센서스에 부합했다.신한생각prediction2027년 바이오 업황 정상화에 따른 이익 레버리지 확대가 주목된다.신한생각statement유가 및 곡물 가격 상승으로 시황이 회복되며 전사 영업이익 개선의 핵심 동력으로 작용하고 있다.신한생각statement중국발 공급 증가와 경쟁 심화로 바이오 실적 부진이 장기화되며 주가가 약세를 보였다.신한생각predictionThe target price is cut 17% to 380,000 won via SOTP valuation, applying a 20% discount to global peer valuation (27F department store EV/EBITDA 5x) reflecting limited ROE improvement; ROE recovery requires active shareholder return policy, and asset value from the high-speed terminal site redevelopment is a valuation normalization factor.신한생각statementDuty-free profit declined quarter-on-quarter (2Q26 333 billion won → 3Q26 253 billion won) due to higher discount rates in the seasonal off-season and a higher cost ratio from a stronger won.신한생각statementDespite increased depreciation from large renewal investment (8.4 billion won), operating profit rose for four consecutive quarters (+23%) on sales-driven leverage, and the depreciation growth rate eases further from 4Q.신한생각statementDepartment store gross sales growth was +8.5% (October -2.8%), down from +15.5% the prior quarter but better than feared, led by large stores (head office +44%) and foreigners (+71%, 7.5% share).신한생각
20 of 40